Estimating the Rate of Accumulating Drug Resistance Mutations in the HIV Genome

This publication has 60 references indexed in Scilit:

• Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection
  The American Journal of Medicine, 2003
• Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults.
  Archives of internal medicine (1960), 2002
• Treatment for Primary HIV Infection: Projecting Outcomes of Immediate, Interrupted, or Delayed Therapy
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
• Cost-Effectiveness of Earlier Initiation of Antiretroviral Therapy for Uninsured HIV-Infected Adults
  American Journal of Public Health, 2001
• HIV in the United States at the turn of the century: an epidemic in transition
  American Journal of Public Health, 2001
• Use of Genotypic Resistance Testing To Guide HIV Therapy: Clinical Impact and Cost-Effectiveness
  Annals of Internal Medicine, 2001
• The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
  New England Journal of Medicine, 2001
• Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine
  Clinical Pharmacology & Therapeutics, 1999
• Correlation of response to treatment and HIV genotypic changes during Phase III trials with saquinavir and reverse transcriptase inhibitor combination therapy
  AIDS, 1998
• Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1998